Meta AnalysisID 7524
矿物质在缺血性心脏病中的作用
CRD42023469280
- What is the significance and role of each selected mineral in the course and pathophysiology of the ischemic heart disease (in other words: what each mineral do in the disease in the heart). - How does dietary mineral
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7524
- Evidence Id
- 16082
- Core Evidence Id
- 16082
- Source Meta Analysis Id
- 7517
- Herb2 Meta Analysis Id
- HBMA007517
- Crd Id
- CRD42023469280
- Title
- The role of minerals in ischemic heart disease
- Review Question
- - What is the significance and role of each selected mineral in the course and pathophysiology of the ischemic heart disease (in other words: what each mineral do in the disease in the heart). - How does dietary mineral intake and mineral supplementation influence the prevention, management and course of ischemic heart disease?
- Study Type Included
- 1-Studies comparing the effects of increased mineral intake with standard or lower levels of mineral intake. 2-Research comparing different minerals and their effects on ischemic heart disease.
- Condition Being Studied
- Ischemia is defined as inadequate blood supply (circulation) to a local area due to blockage of the blood vessels supplying the area. Ischemic means that an organ (e.g., the heart) is not getting enough blood and oxygen. Ischemic heart disease, also called coronary heart disease (CHD) or coronary artery disease, is the term given to heart problems caused by narrowed heart (coronary) arteries that supply blood to the heart muscle. Although the narrowing can be caused by a blood clot or by constriction of the blood vessel, most often it is caused by buildup of plaque, called atherosclerosis. When the blood flow to the heart muscle is completely blocked, the heart muscle cells die, which is termed a heart attack or myocardial infarction (MI). Most people with early (less than 50 percent narrowing) CHD do not experience symptoms or limitation of blood flow. However, as the atherosclerosis progresses, especially if left untreated, symptoms may occur. They are most likely to occur during exercise or emotional stress, when the demand for the oxygen carried by the blood increases.
- Participant
- Inclusion Criteria: Studies investigating the role of minerals in ischemic heart disease or coronary artery disease. Research involving human and animal subjects. Studies examining the impact of mineral intake, supplementation, or status on heart health. Studies published in English. Animal studies. Studies published in the last 8 years. Exclusion Criteria: Studies not relevant to minerals and heart disease. Non-English publications. Studies older than 8 years.
- Animal
- Human Disease Modelled
- Intervention
- Inclusion criteria: Clinical trials or observational studies exploring the role of minerals in preventing, managing, or treating ischemic heart disease. Exclusion criteria: Interventions not related to mineral intake.
- Comparator Control
- Inclusion criteria: 1-Studies comparing the effects of increased mineral intake with standard or lower levels of mineral intake. 2-Research comparing different minerals and their effects on ischemic heart disease. Exclusion criteria: 1-Research comparing minerals that are not directly relevant to the context of ischemic heart disease.
- Main Outcome
- Inclusion criteria: 1-Research on overall cardiovascular health outcomes associated with mineral intake. 2-Investigation of the role of minerals in ischemic heart disease. Exclusion criteria: 1-Studies with outcomes not directly related to ischemic heart disease (e.g., outcomes solely related to other cardiovascular diseases). 2- Research lacking clear assessment or measurement of relevant cardiovascular health outcomes.
- Outcome Measure
- Additional Outcome
- Not applicable
- Study Method
- Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Katarzyna Skrypnik [email protected]
- Organisational Affiliation
- Department of Human Nutrition and Dietetics, Poznan University of Life Sciences
- Funding Source
- National Science Center of Poland Grant number(s) State the funder, grant or award number and the date of award 2021/43/D/NZ7/00660 grand holder: Damian Skrypnik
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Poland
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-12-11
- Registration Date
- 2023-12-22
- Anticipated Start Date
- 2023-12-01
- Anticipated Completion Date
- 2024-06-30
- Title Cn
- 矿物质在缺血性心脏病中的作用
- Title En
- The role of minerals in ischemic heart disease
- Bilingual Status
- complete